Loading clinical trials...
Loading clinical trials...
Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Conditions
Interventions
ABT-493
ABT-530
Locations
3
United States
Site Reference ID/Investigator# 132890
Miami, Florida, United States
Site Reference ID/Investigator# 132889
Orlando, Florida, United States
Site Reference ID/Investigator# 137332
Grafton, Auckland, New Zealand
Start Date
March 1, 2015
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
February 22, 2016
NCT07154901
NCT07165015
NCT06352411
NCT07445906
NCT06661733
NCT07124403
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions